Our purpose
is to reduce the physical, emotional, and economic burdens of obesityOur vision
is that trusted, convenient, and affordable medicines can scale to meet the demands of one of the leading health burdens of our time, and that healthy, sustainable weight loss and maintenance can be an empowering experience.Our Approach
We are a clinical-stage biotechnology company focused on engineering, developing, manufacturing, and ultimately commercializing a new generation of potent, ultra-long acting, scalable nutrient-stimulated hormone (NuSH) therapies for obesity and related diseases.
Our portfolio of injectable and oral therapeutic candidates is designed to:
Reduce barriers to adoption and long-term use, making it easier for people to start and stay on therapy
Enable oral therapy options with injectable-like performance
Engineer step-change improvements in scalability
Raise the ceiling of effectiveness and tolerability
We bring an integrated approach to innovation that spans peptide engineering, agile translational science, efficient clinical development, and large-scale manufacturing – all grounded in a fundamental, jobs-to-be-done view of obesity and overweight.